MARY BAKER: Open Payments
NPI 1750615282 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 8 payments from 8 companies in 2025. Trend: 2023 $476 · 2024 $462 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $143 |
| E.R. Squibb & Sons, L.L.C. | 1 | $131 |
| Gilead Sciences, Inc. | 1 | $126 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Eisai Inc. | 1 | $121 |
| Merck Sharp & Dohme LLC | 1 | $121 |
| PFIZER INC. | 1 | $105 |
| Lilly USA, LLC | 1 | $74 |
Products named: WATCHMAN FLX, BREYANZI, Lenvima, KEYTRUDA, ELREXFIO.
Industry payments across OH — which companies pay providers there.
